<DOC>
	<DOCNO>NCT00765414</DOCNO>
	<brief_summary>This extension study monitor long-term safety efficacy rhGAA treatment single patient infantile-onset Pompe disease previously treat rhGAA Genzyme study .</brief_summary>
	<brief_title>Extension Study Long-term Safety Efficacy Myozyme Single Patient With Pompe Disease Who Were Previously Enrolled Genzyme Sponsored ERT Studies .</brief_title>
	<detailed_description />
	<mesh_term>Metabolic Diseases</mesh_term>
	<mesh_term>Glycogen Storage Disease Type II</mesh_term>
	<mesh_term>Glycogen Storage Disease</mesh_term>
	<criteria>Provide write informed consent prior participate study related procedure ; Currently enrol Protocol AGLU01402 Have ability comply clinical protocol , require extensive clinical evaluation extend period time . Was pregnant unwilling use approve birth control course study ; Had experience unmanageable AEs Protocol AGLU01402 ( determine agree upon Principal Investigator sponsor ) due rhGAA would preclude continue ERT ; Was participate investigational study .</criteria>
	<gender>Female</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2014</verification_date>
</DOC>